Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Gains from Sales and Divestitures (2022 - 2025)

Biofrontera has reported Gains from Sales and Divestitures over the past 4 years, most recently at $225000.0 for Q4 2025.

  • For Q4 2025, Gains from Sales and Divestitures rose 4615.99% year-over-year to $225000.0; the TTM value through Dec 2025 reached $225000.0, up 4615.99%, while the annual FY2025 figure was $225000.0, 4615.99% up from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 was $225000.0 at Biofrontera, roughly flat from $225000.0 in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $170.1 million in Q2 2022 and troughed at $4771.0 in Q2 2024.
  • A 4-year average of $17.1 million and a median of $8588.0 in 2023 define the central range for Gains from Sales and Divestitures.
  • Biggest five-year swings in Gains from Sales and Divestitures: plummeted 94.95% in 2023 and later skyrocketed 4615.99% in 2025.
  • Year by year, Gains from Sales and Divestitures stood at $8504.0 in 2022, then grew by 0.99% to $8588.0 in 2023, then tumbled by 44.45% to $4771.0 in 2024, then skyrocketed by 4615.99% to $225000.0 in 2025.
  • Business Quant data shows Gains from Sales and Divestitures for BFRI at $225000.0 in Q4 2025, $225000.0 in Q3 2025, and $4771.0 in Q4 2024.